Clinical Trial Update: This Is A Study Of Bioavailability And Food Effect For Fesoterodine. [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study to assess the bioavailability of fesoterodine and the effect of food on its pharmacokinetics in adults with overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency | Phase 1 | Status: COMPLETED | Results posted: 2012-01-09